NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab

by Nathalie I. Bouwer, Crista Liesting, Marcel J. M. Kofflard, Sylvia M. Sprangers-van Campen, Jasper J. Brugts, Jos J. E. M. Kitzen, Michael A. Fouraux, Mark-David Levin, Eric Boersma
Published 2019-05-01